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Jackson, MississippiABSTRACT The therapeutic potential of elastin-like polypeptide (ELP) conjugated to therapeutic compounds is currently being
investigated as an approach to target drugs to solid tumors. ELPs are hydrophobic polymers that are soluble at low temperatures
and cooperatively aggregate above a transition temperature (TT), allowing for thermal targeting of covalently attached drugs.
They have been shown to cooperatively transition from a disordered structure to a repeating type II b-turn structure, forming
a b-spiral above the TT. Here we present biophysical measurements of the structural, thermodynamic, and hydrodynamic prop-
erties of a specific ELP being investigated for drug delivery, ELP[V5G3A2-150]. We examine the biophysical properties below
and above the TT to understand and predict the therapeutic potential of ELP-drug conjugates. We observed that below the
TT, ELP[V5G3A2-150] is soluble, with an extended conformation consisting of both random coil and heterogeneous b structures.
Sedimentation velocity experiments indicate that ELP[V5G3A2-150] undergoes weak self-association with increasing tempera-
ture, and above the TT the hydrophobic effect drives aggregation entropically. These experiments also reveal a previously un-
reported temperature-dependent critical concentration (Cc) that resembles a solubility constant. Labeling ELP[V5G3A2-150] with
fluorescein lowers the TT by 3.5
C at 20 mM, whereas ELP[V5G3A2-150] dissolution in physiological media (fetal bovine serum)
increases the TT by ~2.2
C.INTRODUCTIONElastin-like polypeptides (ELPs) are thermoresponsive bio-
polymers that consist of repeating pentapeptide sequences
of the amino acids Val-Pro-Gly-Xaa-Gly (VPGXG, where
X can be any common amino acid other than proline).
Below the transition temperature (TT), ELPs are soluble in
aqueous solutions and assumed to be monomeric, but above
the TT, ELPs desolvate and hydrophobic interactions pro-
mote the formation of what is widely reported to be a b-spi-
ral conformation that is coupled to aggregation (1). This
aggregation process is physically similar to a phase change
and the TT is sometimes referred to in the literature as a
lower critical solution temperature (1). The TT of an ELP
is a concentration-dependent parameter that is unique to
each polymer and inversely related to the concentration,
number of monomer repeats, and hydrophobicity of the
fourth or variable X residue of the pentapeptide repeat
(2–5). Because of the dependence of the TT on physical
properties that can be manipulated by altering the X compo-
sition, new ELPs can be rationally designed with any
desired TT. An excellent summary of engineering an ELP
with a precise TT can be found in Chilkoti et al. (3).
Many novel ELPs have been designed and a nomenclature
has been developed (3) so that any ELP can be described by
ELP[X#X#X#  n], where X represents guest residues in the
pentapeptide, # is the number of pentapeptide repeats with
that residue, the sum of the #s gives the number of pentapep-Submitted October 24, 2012, and accepted for publication March 12, 2013.
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0006-3495/13/05/2009/13 $2.00tides within a repeating monomer unit, and n represents the
total number of pentapeptide repeats in the overall protein.
To illustrate the nomenclature using the ELP peptide under
study, ELP[V5G3A2-150] is a polymer with a repeating
monomer unit consisting of three different pentapeptides
(VPGVG, VPGGG, and VPGAG, in a ratio of 5:3:2, respec-
tively (Table 1)). The repeating monomer has a total of 10
pentapeptide blocks, and the total length of the ELP
[V5G3A2-150] polymer is comprised of 15 monomer units,
totaling 150 pentapeptide repeats (or 750 amino acid resi-
dues). There is also anMSKGPG sequence at the N-terminal
region, with the lysine engineered for drug attachment, and a
WP capping sequence at the C-terminal end (see Table 1).
Any small molecules or peptide therapeutics can be chem-
ically conjugated to ELP and delivered systemically. At
physiological temperatures, the ELP-drug conjugate is solu-
ble and is believed to circulate as monomers (3,6–17). When
a specific area, such as a tumor, is heated through high-inten-
sity focused ultrasound, radiofrequency, or microwaves, the
ELP will aggregate and localize the drug to the site of heat-
ing (3). Cellular uptake of localized ELP is facilitated by
N-terminal attachment of a cell-penetrating peptide (CPP)
that stimulates endocytosis (6). Among the peptides previ-
ously conjugated to ELP[V5G3A2-150] and used for delivery
in cell and animal models by Raucher and co-workers are the
GRG peptide (7), p21 peptide (8,9), c-Myc peptide (10–13),
and L12 peptide (14). ELP[V5G3A2-150] has also been con-
jugated to a number of small-molecule drugs, including
doxorubicin (15,16) and Paclitaxel (17). These studieshttp://dx.doi.org/10.1016/j.bpj.2013.03.040
TABLE 1 Protein sequence information
Molecular mass pI Average disorder Emolar <H> RH
D RH
F
59,546.61 Da 8.875 .9902 5690 0.5894 8.88 nm 3.26 nm
ELP[V5G3A2-150] sequence
N0 - MSKGPG (VPG[VGAVVVGAGV]G)15WP – C0
Average disorder is defined by averaging the predicted disorder over the entire polypeptide, where 0 indicates a high probability of order and 1 a high prob-
ability of disorder. <H> is the mean hydrophobicity of the polypeptide. RH
D is the predicted hydrodynamic radius of a completely disordered protein with a
high proline content of the same residue number. RH
F is the predicted hydrodynamic radius of a globular protein of the same residue number. The repeating
10-pentapeptide sequence of ELP is presented in a condensed format by showing the composition of 10 sequential pentaptide repeats (VPG[X]G), where the
identity of each guest residue, X, is presented in brackets.
2010 Lyons et al.have demonstrated the ability of ELP[V5G3A2-150] to in-
crease the targeting and efficacy of systemically delivered
therapeutics relative to free therapeutics.
The structural changes and thermodynamic properties of
ELP aggregation at high temperature have been explored for
ELPs of different lengths and guest residue compositions
similar to that of ELP[V5G3A2-150] (4,5). However, the hy-
drodynamic and solution properties of ELP constructs have
not been previously investigated. Hydrodynamic analysis is
crucial for therapeutic development (and often required by
the U.S. Food and Drug Administration) because it is
uniquely suited to describing solution behavior. Several
questions remain to be addressed: 1), is the therapeutic
construct monomeric or does it self-associate below the
TT; 2), does the therapeutic construct interact with plasma
proteins; and 3), is the TT for ELP[V5G3A2-150] affected
by the macromolecular crowding present in physiological
media such as fetal bovine serum (FBS)?
In this study we investigated the structural, thermody-
namic, and hydrodynamic properties of ELP[V5G3A2-150]
over a range of temperatures below and above the TT,
with the goal of understanding how ELP[V5G3A2-150] be-
haves both in PBS and in physiological buffer. We analyzed
the TTof ELP[V5G3A2-150] as a function of temperature us-
ing turbidity. The size and size distribution were determined
at temperatures ranging from below the TT to above the TT
using dynamic light scattering (DLS). The enthalpy change
for the aggregation reaction was determined using differen-
tial scanning calorimetry (DSC) and the secondary structure
was investigated using circular dichroism (CD). Analytical
ultracentrifugation (AUC; specifically, sedimentation veloc-
ity (SV) experiments) was used to determine the hydrody-
namic properties of ELP[V5G3A2-150].MATERIALS AND METHODS
Information regarding the materials and methods used in this study is pro-
vided in the Supporting Material.RESULTS
Sequence analysis
The ELP under study (ELP[V5G3A2-150]) is a 758 residue
polypeptide with a molecular mass of 59,546.61 DaBiophysical Journal 104(9) 2009–2021(Table 1). It is predicted by the software utility PONDR
(18–20) to be highly disordered throughout its entire
sequence, with an average disorder prediction of 0.9902 (Ta-
ble 1). This is to be expected given the high proline content.
This prediction of disorder is consistent with the prevailing
view of ELPs as intrinsically disordered proteins (IDPs)
below the TT. ELP[V5G3A2-150] contains 15 repeating units
of 10 pentapeptide residues with a mean hydrophobicity
<H> of 0.589 (21). IDPs are often grouped according to
how compact they are in solution, and it is believed that
ELP adopts an extended conformation in solution (1,3–5).
For comparison with experimental values presented in the
following sections, we calculated the hydrodynamic radii
for a folded or globular protein of the same numbers of res-
idues as ELP[V5G3A2-150] (Table 1) using the simple po-
wer law relationship:
RH ¼ R0Nv (1)
where N is the total number of residues, and R0 and v are
constants determined by Wilkins et al. (22) (R0 ¼ 4.75
and v ¼ 0.29). In a recent study, Marsh and Forman-Kay
(23) demonstrated a method to calculate the hydrodynamic
radius for an extended or unfolded IDP with a high proline
content:
RH ¼

APpro þ B
ðCjQj þ DÞSHis$R0Nv (2)
where Q is the charge; P ¼ fraction prolines; SHis ¼ 1 since
no histidine tag is present; and A, B, C, D, Ro, and v are con-
stants (A ¼ 1.24,, B ¼ 0.904, C ¼ 0.00759, D ¼ 0.963,
R0 ¼ 2.49, and v ¼ 0.285, 0.549, or 0.509 for folded, dena-
tured, or IDP states, respectively). The calculated and pre-
dicted hydrodynamic radii for ELP[V5G3A2-150] in a
folded (RH
F) or denatured (RH
D) state are 3.26 and
8.88 nm, respectively (Table 1). This result for the folded
state is in agreement with an estimate for a typical folded
protein with the same molecular weight as ELP assuming
a frictional ratio f/f0 of 1.2, RS ¼ 3.2 nm.Examination of the TT of ELP[V5G3A2-150]
The TT is the concentration-dependent temperature at which
an ELP will aggregate and thus localize systemically
delivered therapeutics. We determined the TT for ELP
FIGURE 1 Examining the inverse thermal transition (the aggregation of
ELP at high temperatures) of ELP[V5G3A2-150] by turbidity. (A) Revers-
ible turbidity data of ELP[V5G3A2-150] as the temperature is raised or
the solution is heated, then cooled, and the entire process repeated. (B)
Open triangles are the TT of ELP[V5G3A2-150] at each concentration in
PBS, giving a best fit for TT ¼ 46.75C – 4.79*log[ELP[V5G3A2-150]].
Solid squares are the Cc or soluble concentration from SV experiments at
the given temperatures. Solid diamonds are the measured TT of ELP
[V5G3A2-150] in 95% FBS, giving a best fit for TT ¼ 49.80C 
5.426*log[ELP[V5G3A2-150]]. Solid triangles are the measured TT of fluo-
rescein-labeled ELP[V5G3A2-150] in PBS, giving a best fit for TT ¼
43.14C  5.44*log[ELP[V5G3A2-150]].
FIGURE 2 Overlay of turbidity (open diamonds) with RH (solid squares,
obtained from DLS) and DCp (open squares) of ELP[V5G3A2-150] as a
function of temperature.
Hydrodynamic Analysis of ELP[V5G3A2-150] 2011[V5G3A2-150] by measuring the turbidity in PBS as a func-
tion of temperature. The turbidity remained constant at low
temperatures until a sharp and cooperative increase occurred
at the TT (Fig. 1 A). We examined the reversibility of the
ELP[V5G3A2-150] aggregation process by repeatedly heat-
ing and cooling a solution of ELP[V5G3A2-150] (Fig. 1 A).
(The reversibility was measured at 1.0C/min and could not
be measured at a slower heating rate (e.g., 0.1C/min)
because the aggregates formed would slowly pellet to the
bottom of the cuvette from the force of gravity. Even if
they were mixed, the hysteresis would persist because ag-
gregation and resolubilization occur at different rates. The
TT was measured at 0.1
C/min to improve overlap among
the turbidity, DLS, and DSC data (see below).)
The overlay of the heating and cooling profiles indicates
that the aggregation process is both reversible and repeat-
able. A hysteresis between the aggregation and disassemblyprofiles suggests a difference in the kinetics of the two pro-
cesses. The TT was measured as a function of concentration
of ELP[V5G3A2-150] and an inverse relationship was
observed between ELP[V5G3A2-150] concentration and
the TT (Fig. 1 B, open triangles). The inverse dependence
of TT on concentration was previously measured for other
ELPs (2) and determined to be a linear function when
plotted on a log scale according to
TT ¼ T0T m  log½ELP (3)
where TT
0 is the extrapolated TT at infinite dilution. This
was measured for ELP[V5G3A2-150] from 156 nM to 800
mM (3.71 orders of magnitude) and found to agree with
this published relationship with a best-fitted equation of
TT ¼ 46.75C – 4.79*log[ELP[V5G3A2-150]] (Fig. 1 B).Examination of the change in size and heat
capacity during the aggregation process
We measured the hydrodynamic radius of ELP[V5G3A2-
150] as a function of temperature using DLS (Fig. 2). Below
the TT at 5
C and 130 mM, ELP[V5G3A2-150] has a hydro-
dynamic radius (RH) of 6.95 nm 5 0.13 (Table 2), a value
smaller than the 8.88 nm RH
D state described above. This
result is consistent with an unstructured and extended ELP
monomer that has the additional compaction or constraint
of a proline-rich IDP.
As the temperature increases at this concentration, the RH
increases to 8.60 nm5 1.09 directly below the TT. This in-
crease in RH can be attributed to either an unfolding of ELP
[V5G3A2-150] with increasing temperature (the denatured
state RH
D ¼ 8.88 nm) or association into oligomers below
the TT. Above the TT, ELP[V5G3A2-150] forms aggregates
that are ~250 times larger, with an RH of 2.32 mm5 0.39.
These experiments were repeated at three concentrations
(Table 2; Fig. S1, A and B). Note that the RH just below TTBiophysical Journal 104(9) 2009–2021
TABLE 2 Summary of values calculated from DLS and DSC (Fig. 2)
[ELP[V5G3A2-150]] RH at 5
C (nm) RH at T<TT (nm) RH at T>TT (nm) DH (kcal/mol) DH (kJ/mol) Literature DH (kJ/mol)
130 mM 6.955 0.13 8.605 1.09 23205 390 46.4 194 34 (27)
260 mM 6.875 0.20 9.405 0.32 26705 460 45.5 190 84 (29)
390 mM 6.775 0.12 11.455 0.67 23905 840 45.7 191 300 (30)
600 (28)
RH is the hydrodynamic radius measured by DLS. RH T<TT is the hydrodynamic radius measured at the temperature immediately below the TT and thus is
concentration dependent. Note that measuring particle sizes in the micrometer range would require static light scattering measurements taken over ~10 hr.
Therefore, the RH T>TT size measurements are estimates of the true size above the TT. The DLS measurements use an autocorrelation function to obtain the
distribution of particle sizes present in a sample. The precision of the reported DLS measurements is the result of making replicate measurements and re-
porting the average value for the mean of the size distributions.
2012 Lyons et al.increases with protein concentration (9.40 nm at 260 mMand
11.45 nm at 390 mM), suggesting this is not due to unfolding.
The superposition of the turbidity and DLS data verify that
the increase in turbidity above the TT is caused by the coop-
erative association of ELP[V5G3A2-150]. These data are
consistent with previous turbidity (3,9) and DLS (3) data
for ELPs. (Above the Tt, aggregates begin to precipitate.
Because the DLS measurement is done at the bottom of
the cell and the turbidity measurements are done in the mid-
dle of the cuvette, the change in aggregate concentration
with time results in the differences in the high-temperature
data. In other words, the turbidity measurements initially
reflect a homogeneous distribution of large particles distrib-
uted throughout the cell, but as the particles aggregate and
precipitate, the turbiditymeasurements reflect the concentra-
tion of the particles left in the supernatant. Due to cell design
differences, this effect is attenuated in the DLS cell, but in
fact at higher temperature or longer times, even the DLS
data show some decrease in the particle size distribution.)
The enthalpy change for the phase transitionwasmeasured
usingDSC (Fig. 2), and theDHvalues are reported in Table 2.
The positive enthalpy change of 46 kcal/mol (192 kJ/mol)
indicates that the phase transition is an endothermic process,
consistent with processes involving the desolvation of the
polymer coupled to the aggregation. Interchain interactions
(e.g., weak van der Waals interactions) would yield a small
exothermic contribution to the overall transition enthalpy
change. ELP transition enthalpy changes reported in the liter-
ature vary widely from as low as 34 kJ/mol (24) to >800 kJ/
mol (25–27). TheDH values reported here appear to be inde-
pendent of ELP[V5G3A2-150] concentration, at least over the
range of 130–390 mM. However, as was previously reported,
DH depends on salt concentration (28); the values reported
here were obtained in PBS at an ionic strength of 0.14 M.
The average of our ELP[V5G3A2-150] transition DH values
(192 kJ/mol) falls near the mean of the previously reported
values for similar ELP constructs (see Table 2).Examination of the polypeptide secondary
structure below and above the TT
To elucidate the structural changes that accompany the
aggregation process, we examined the secondary structureBiophysical Journal 104(9) 2009–2021using CD over a range of temperatures below and above
the TT (Fig. 3, A–C). The shape of the CD spectra obtained
as a function of temperature is consistent with previous re-
sults obtained on ELP constructs by four different research
groups (28–31), with a temperature-dependent minimum at
195 nm, a temperature-dependent maximum at 210 nm, and
a temperature-independent minimum at 225 nm. The CD
spectrum for an ELP was first interpreted by Urry et al.
(29), who determined that the minimum at 195 nm was
caused by a random or disordered polypeptide structure,
and that the maximum at 210 nm above the TT was caused
by a repeating type II b-turn structure forming a b-spiral.
This analysis was supported by Reiersen et al. (30). Nicolini
et al. (28), however, analyzed the spectra to indicate a
mixture of both random and b-turns/strands that changed
in relative percentages with increasing temperature. Their
analysis indicated that the minimum at 225 nm, present
both below and above the TT, was caused by type II b-turns;
however, the variation observed in b-sheet structures (e.g.
antiparallel, parallel, mixed, intra-/intermolecular, and de-
gree of twisting) makes it impossible to rule out some
form of b-sheets (32).
The sudden increase in the turbidity, DLS, and DSC data
at the TT suggested a cooperative association model in
which ELP[V5G3A2-150] sharply transitions from a soluble
state to a fully aggregated and insoluble state. This sudden
and cooperative transition of ELP[V5G3A2-150] from solu-
ble monomer to insoluble aggregate is widely reported in
the literature (2). However, the decreasing magnitude of
the minima at 195 nm in the CD spectra with increasing
temperature, and the gradual change in the percentage of
disordered structure also suggest that ELP[V5G3A2-150]
exists in an equilibrium between monomer and a structure
that shifts toward aggregate with increasing temperature.
In fact, Urry et al. (29) noted that the signal was less than
would be expected for a fully disordered structure. An equi-
librium below TT is also supported by the molecular-dy-
namics simulations conducted by Baer et al. (33) on a
capped octapeptide GVG(VPGVG) sequence. These results
led us to look at the hydrodynamic properties of ELP
[V5G3A2-150] as a function of temperature, with the expec-
tation that intermolecular interactions may be occurring
below the TT.
FIGURE 3 Examining the secondary structure of ELP[V5G3A2-150] dissolved in PBS using CD (mean residue ellipticity) as a function of concentration
and temperature, indicated by arrows pointing to individual spectra. TT ¼ 41.17C, 41.03C, and 40.22C at concentrations of (A) 0.62 mg/mL, (B)
0.98 mg/mL, and (C) 1.23 mg/mL, respectively. (D) Plotting the mean residue ellipticity at 196 nm as a function of concentration and temperature. Note
the shift in ellipticity with concentration consistent with a structural change coupled to association.
Hydrodynamic Analysis of ELP[V5G3A2-150] 2013Examination of the hydrodynamic properties of
ELP[V5G3A2-150]
To study the hydrodynamic and intermolecular interaction
properties of ELP[V5G3A2-150], we used SV to measure
the apparent sedimentation coefficient of ELP[V5G3A2-
150] equilibrated in PBS as a function of concentration
and temperature. The S20,W was calculated from g(s*) anal-
ysis (Fig. 4) (34,35) and plotted as 1/S20,w against the con-
centration of ELP[V5G3A2-150] (Fig. 5 A). At 5
C the
S20,W decreases with increasing concentration. This inverse
relationship is explained by hydrodynamic nonideality Ks,
an empirical term that is in part a function of how extended
the molecule is in solution and therefore how much fric-
tional force (f) the solvent exerts on the molecule as it sed-
iments. (The primary charge effect (36) also contributes to
this slope in low-salt buffers; however, ELP has a very small
charge (þ1) under these conditions.)
f ¼ f0ð1þ Ks$cÞ (5)
where f0 is the frictional coefficient extrapolated to zero
concentration. As the concentration of ELP[V G A -150]5 3 2increases, the sedimentation coefficient decreases according
to (37)
s ¼ Mð1 vrÞ
NAf0ð1þ KscÞ ¼
s0
ð1þ KscÞ (6)
By plotting the 1/S20,W as a function of concentration, we
0can extrapolate the S20,W to zero concentration (S 20,W),
where the nonideality is negligible, and the slope of the
data will directly give Ks/so. (There are multiple conven-
tions in the AUC field for analyzing the concentration
dependence of S, including a Taylor expansion form in
which s ¼ so(1  Ksc) (38). Many nanopolymer studies
are done on a volume fraction scale (39). The s and 1/s
inverse formats are typically expressed on a weight concen-
tration scale for biomolecules. In this case, for ELP
[V5G3A2-150], 1 mg/mL ¼ 16.79 mM for comparison
with other data sets.) This S020,W can be used to calculate
the frictional ratio (f/f0), which is a measure of how
extended a molecule is relative to a spherical particle of
the same mass. At 5C, f/f0 ¼ 2.62 (Table 3), indicating
an extended conformation (for a globular hydrated protein,
f/f0 ¼ ~1.2), consistent with the low-temperature CD data.Biophysical Journal 104(9) 2009–2021
FIGURE 4 Normalized g(s*) summary of SV data collected at each temperature and multiple concentrations. The decrease in the boundary position with
increasing concentration is caused by hydrodynamic nonideality, Ks, a measure of excluded volume. This trend in the data is reduced at higher temperatures,
and by 35–37C the boundaries are shifting to higher S-values consistent with self-association. As discussed in the text, this self-association is hidden by the
nonideality throughout the temperature range and requires constraining Ks and BM1 to determine the magnitude of indefinite association K (M
1) by global
fitting. (A) 5C. (B) 10C. (C) 20C. (D) 30C. (E) 35C. (F) 37C.
2014 Lyons et al.The RH calculated from the f/f0 is 6.92 nm, which is very
similar to the RH measured from the low-temperature DLS
data (6.77–6.95 nm; Fig. 2, summarized in Table 2). To
verify that the 5C SV data correspond to a nonideal mono-
mer, the six experimental data sets were analyzed globally
by Sedanal direct boundary fitting (40), revealing random
residuals and a best fit consist with monomeric ELP
(Fig. S2).
As the temperature is increased, the observed hydrody-
namic nonideality (the slope of a 1/s versus c plot; Fig. 5
A) decreases until at 35C there is no observable apparent
nonideality. This is more apparent in the family of normal-
ized g(s*) curves (Fig. 4), where a nonideal or centripetal
shift occurs with increasing concentration at low tempera-
tures and an apparent nonassociating or weak centrifugal
shift occurs at high temperatures. This could be attributed
to compaction of ELP[V5G3A2-150] with increasing tem-Biophysical Journal 104(9) 2009–2021perature. However, the RH measured by DLS increases
with temperature below the TT, which is not consistent
with compaction. In addition, although the f/f0 does
decrease slightly with temperature (from 2.62 to 2.33), it
still indicates an extended conformation. Therefore, the
temperature-dependent decrease observed in the apparent
nonideality (Ks; Table 3) and the increase in RH measured
by DLS can best be interpreted as weak association below
the TT.
To better understand the effects of weak association on a
nonideal system, we performed a series of SV simulations of
a nonideal monomer-dimer system. The goal of the simula-
tions was to test the hypothesis that weak association would
cause a proportional decrease in the observed inverse con-
centration dependence of the S20,W and therefore mask the
nonideality of the system. The simulations assumed experi-
mental conditions and a constant Ks (mL/mg) value for both
FIGURE 5 The hydrodynamic properties of ELP[V5G3A2-150] were analyzed by measuring the weight average sedimentation coefficient over a range of
concentrations and temperatures. (A) 1/S20,W as a function of concentration at multiple temperatures. The slope of each line provides an estimate of Ks (sum-
marized in Table 3). (B) Simulated SV data of a monomer-dimer system with increasing association (K2¼ 103, 104, 105, and 106 M1). The monomer data are
simulated assuming the experimental values of So20,w and Ks at 5
C (A). The dimer is assumed to sediment at 1.59  S1. (C) Plot of the experimental S20,W
/S020,W as a function of concentration at multiple temperatures. (D) S20,W/S
0
20,W of the simulated monomer-dimer system with increasing association.
Hydrodynamic Analysis of ELP[V5G3A2-150] 2015monomer and dimer. A family of data sets was generated as
a function of concentration and over a range of association
constants. These data sets were analyzed by DCDTþ to
generate g(s*) and to extract weight average S values, which
are plotted as 1/S20,w versus concentration (Fig. 5 B). The
simulated data (Fig. 5 B) exhibit the expected increase inTABLE 3 Summary of values calculated from SV (Figs. 4 and
5) below the TT
Temp (C) S0 f/f0 Ks
5C 1.890 S20,W 2.62 0.06076 mL/mg
10C 1.937 S20,W 2.55 0.05649 mL/mg
20C 1.995 S20,W 2.49 0.03320 mL/mg
30C 2.124 S20,W 2.34 0.01323 mL/mg
35C 2.121 S20,W 2.33 0.00318 mL/mg
S0 is the sedimentation coefficient extrapolated to zero concentration. f/f0 is
the frictional ratio and is calculated from the S0. Ks is the hydrodynamic
nonideality, a measure of the decrease in the sedimentation coefficient
with increasing concentration, and estimated from the slope of a plot of
1/S20,W versus c.apparent S with increasing association, and the data
obtained at K2 ¼ 104 M1 are most consistent with the
30C experimental data. The simulated data also exhibit a
change in the extrapolated S20,W values consistent with a
higher extent of dimer present with larger K2 values,
although at the higher K2 values the association is dominant
over the nonideality and thus the slope is not decreasing.
The model assumes no change in the f/f0, and thus the in-
crease in the observed S020,W in the simulations indicates
that association will affect not only the concentration depen-
dence but also the apparent f/f0. This suggests that the
change in S020,W seen in the experimental data may also
be attributed to weak association and, consistent with the
DLS data collected, need not be due to a compaction of
the polypeptide.
A recent method developed by Rowe (39) to examine
weak association is to plot the ratio of S20,W/S
0
20,W as a
function of concentration. Plotting the ratio emphasizes
the effects of weak, concentration-dependent behavior (non-
ideality and self-association) by normalizing sedimentationBiophysical Journal 104(9) 2009–2021
TABLE 4 Summary of direct boundary fitting of SV data
Temp (C) K (M1) 95% CI RMSD
Model: A
10C 1.708E-2
20C 2.511E-2
30C 5.161E-2
35C 1.053E-1
Model: A þ A h-i A2
10C 4.063Eþ2 h3.926Eþ2, 4.202Eþ2i 1.286E-2
20C 2.526Eþ3 h2.473Eþ3, 2.580Eþ3i 1.125E-2
30C 1.622Eþ4 h1.593Eþ4, 1.651Eþ4i 1.219E-2
35C 9.997Eþ4 h9.932Eþ4, 1.075Eþ5i 4.265E-2
Model: A þ A h-i A2 þ A h-i A3
10C 3.664Eþ2 h3.631Eþ2, 3.681Eþ2i 1.299E-2
20C 1.507Eþ3 h1.487Eþ3, 1.538Eþ3i 1.218E-2
30C 6.656Eþ3 h6.637Eþ3, 6.684Eþ3i 7.872E-3
35C 1.603Eþ4 h1.578Eþ4, 1.634Eþ4i 3.319E-2
Model: A þ A h-i A2 þ A h-i A3 þ A h-i A4
10C 3.64Eþ2 h3.627Eþ2, 3.671Eþ2i 1.301E-2
20C 1.359Eþ3 h1.334Eþ3, 1.381Eþ3i 1.272E-2
30C 5.303Eþ3 h5.276Eþ3, 5.337Eþ3i 8.167E-3
35C 9.551Eþ3 h9.537Eþ3, 9.584Eþ3i 2.943E-2
Model: A þ A h-i A2 þ A h-i A3 þ A h-i A4 þ A h-i A5
10C 3.634Eþ2 h3.608Eþ2, 3.668Eþ2i 1.301E-2
20C 1.799Eþ3 h1.774Eþ3, 1.819Eþ3i 1.171E-2
30C 4.953Eþ3 h4.928Eþ3, 4.976Eþ3i 8.965E-3
35C 9.551Eþ3 h9.512Eþ3, 9.586Eþ3i 2.088E-2
Model: indefinite isodesmic association
10C 3.512Eþ2 h3.392Eþ2, 3.632Eþ2i 8.911E-3
20C 1.945Eþ3 h1.912Eþ3, 1.960Eþ3i 6.382E-3
30C 5.301Eþ3 h5.272Eþ3, 5.325Eþ3i 6.520E-3
35C 9.119Eþ3 h9.087Eþ3, 9.138Eþ3i 7.563E-3
Results from globally fitting raw SV data at each temperature to association
models. The best-fit values from 5C (Ks¼ 0.061 and BM1¼ 0.1714) were
held constant for each fit, and the extent and strength of association were
floated. The apparent s1 value was held constant at the 5
C value, deter-
mined from the extrapolated data in Fig. 5 A, but corrected for temperature
in the other data sets. Note that these values do not correspond to the extrap-
olated values, which include the effects of association as discussed in Fig. 5.
The sn was assumed to increase according to s1n
2/3, which may underesti-
mate the values of K (40). For each fit, the K was fixed to be constant for
each step of polymerization (e.g., K2 ¼ K3 etc.). The same parameters
were used for the indefinite, isodesmic fits; however, the extent of associa-
tion was not restricted.
2016 Lyons et al.coefficients to the same scale. We divided the weight
average sedimentation coefficient collected at each temper-
ature by the extrapolated sedimentation coefficient from
5C, thereby normalizing all sedimentation coefficients to
the S020,W of ELP[V5G3A2-150] exhibiting no association
or nonideality (Fig. 5 C and Fig. S2). In addition, the esti-
mated S020,W and concentration dependence of a hypotheti-
cal ELP[V5G3A2-150] dimer (Fig. 5 C, dash-dotted line) are
plotted as a reference. The simulated data are plotted in a
similar manner (Fig. 5 D). The simulated S20,W/S
0
20,W
data approach the pure dimer line above K2 ¼ 106, whereas
the extrapolated values also increase and approach the dimer
S020,W value. The experimental S20,W/S
0
20,W plot (Fig. 5 C)
exhibits an increasing slope with temperature, which we
have already attributed to weak association. It is also
apparent that the ratio S20,W/S
0
20,W at 35
C and high con-
centration exceeds that expected for a dimer, indicating
that association beyond dimer is occurring. Finally, the
extrapolated values increase at each temperature; however,
the increase is far less than that seen in the simulated
data, where K2 approaches 10
6 M1. This analysis by the
Rowe method thus suggests that the appropriate fitting
model for the high temperature SV data sets is weak associ-
ation (~104 M1) that extends beyond dimer.
To quantify the extent and strength of the association, we
analyzed the raw SV data from each temperature globally by
Sedanal direct boundary fitting to a series of stepwise asso-
ciation models (Table 4). This is consistent with the Rowe
method analysis applied above and explores the possibility
that a discrete species serves as a nucleus. We obtained
reasonably good fits (Table 4) by fitting the 10C and
20C data to a nonideal monomer-dimer model, the 30C
data to a monomer-dimer-trimer model, and the 35C data
to a monomer up to pentamer model. This series of best
fits suggests that the extent of association may not be limited
in size, but rather may increase indefinitely. Consequently,
the fits were repeated with a model that assumed weak, in-
definite association (40). This model fits the various data
sets much better, as indicated by root mean-square deviation
(RMSD) values of 0.006–0.009 (Table 4), which demon-
strate that a nonideal indefinite polymerizing model best de-
scribes the data. The presence of weak association seen in
the SV data and the increasing percentage of b-structure
below the TT in the CD data suggest that loss of disorder,
or gain of structure, with increasing temperature is coupled
to the self-association of ELP.
When SV was performed at or above the TT, the ELP
[V5G3A2-150] aggregated and pelleted at 1 K rpm, leaving
behind a constant concentration that sedimented at the same
S20,Wobserved at 30
C and 35C. This critical concentration
(CC) decreased as the temperature increased (Table S1),
consistent with an entropically driven polymerization pro-
cess. The Cc is consistent within experimental error with
the concentration at which ELP[V5G3A2-150] will aggre-
gate by turbidity measurements at specific temperaturesBiophysical Journal 104(9) 2009–2021(solid squares in Fig. 1 B; inflection points in Fig. 2). This
indicates that ELP[V5G3A2-150] does not fully aggregate
at a specific temperature, but associates until the Cc for
that temperature is reached. This suggests that although
the aggregation process is cooperative, it might be appro-
priate to also describe the process as a solubility constant
that is temperature dependent. The TT description accu-
rately described the model of ELP[V5G3A2-150] transition-
ing from a disordered, completely soluble phase to an
ordered, insoluble phase at a specific temperature. However,
the Cc observed in SV indicates that ELP[V5G3A2-150] also
Hydrodynamic Analysis of ELP[V5G3A2-150] 2017exists in a temperature-dependent equilibrium between
these two phases. The analysis of the CD spectra also sug-
gests that a cooperative, structural transition does not
explain the aggregation of ELP[V5G3A2-150], but rather
an equilibrium where the relative amount of order in-
creases. This equilibrium between two phases is accurately
described by a solubility constant and a phase diagram (41).
It is not clear whether a minimum size aggregate or a distri-
bution of aggregate sizes, i.e., a nucleus, is required to
initiate the phase transition at TT.FIGURE 6 Analysis of the behavior of ELP[V5G3A2-150] in FBS. (A)
Turbidity data of 40 mM ELP[V5G3A2-150] in 95% FBS, blanked against
95% FBS, demonstrating the reversibility of aggregation in serum. The
solid line and dotted lines demonstrate the first and second ramps of the
temperature from 20C to 45C, and the dashed and dash-dotted lines
demonstrate the first and second ramps of the temperature from 45C to
20C. The inset represents the turbidity of 100% FBS blanked against
PBS over the same temperature range. The four lines shown in the inset
overlay perfectly, demonstrating that the turbidity of FBS does not change
during a temperature jump. (B) Analysis of weight average sedimentation
coefficients of fluorescein-labeled ELP[V5G3A2-150] sedimenting in FBS
at 20C (solid triangles) and 30C (open triangles). These data are cor-
rected for temperature and the density of FBS solutions from measurements
in an Anton Paar DMA5000.Turbidity and hydrodynamic analysis in FBS
The TT of ELP[V5G3A2-150] constructs designed for drug
delivery is usually measured in either PBS or cell culture
media (7–17). We measured the reversibility of thermal ag-
gregation, the TT, and the hydrodynamic properties in FBS
as an alternative to human serum, to determine how the sys-
tem would behave in the physiological environment.
We found the thermal aggregation of ELP[V5G3A2-150]
in 95% FBS to be completely reversible, consistent with
the behavior in PBS (Fig. 6 A). The TT in FBS was measured
by 20 dilution of a concentrated stock of ELP[V5G3A2-
150] into 100% FBS to make a standard 95% FBS solution.
The TTof ELP[V5G3A2-150] in 95% FBS is increased 2.2
C
at 20 mM (Fig. 1 B), and the slope of the TT as a function of
concentration is increased. This increase in the TT or solubi-
lity of ELP[V5G3A2-150] in FBS is opposite to the expected
consequence of macromolecular crowding, where the
increased activity of each serum component and mass action
should promote assembly or aggregation (42), excluding ef-
fects due to ionic strength. This suggests that there is some
favorable interaction between ELP[V5G3A2-150], in the sol-
uble form, and serum proteins that inhibits aggregation, in
similarity to a sequestering mechanism. This led us to
examine the hydrodynamic properties of fluorescein-labeled
ELP[V5G3A2-150] in FBS to determine whether ELP
[V5G3A2-150] was forming complexes with serum proteins.
Fluorescein-labeled ELP[V5G3A2-150] was produced
and characterized as described in the Supporting Material.
When 1 mM FELP[V5G3A2-150] was sedimented in FBS,
a boundary anomaly was observed (Fig. S5 B) that was
attributed to the Johnston-Ogston (J-O) effect (43–46).
The J-O effect is due to the nonideality or molecular crowd-
ing serum proteins exhibit on slower-sedimenting species
like ELP. The slowly sedimenting species build up during
the run into a boundary that sharpens due to a faster sedi-
mentation rate above the serum interface, and that continues
to grow as more material is forced behind during the run.
Analysis of this data by DCDTþ and Sedfit revealed that
the boundary apparently runs significantly more slowly
than ELP in PBS, in part due to the increased density and
viscosity of serum. We attempted to calibrate the data by
varying the percentage of FBS (Fig. 6 B) and performing
SV experiments at 20C and 30C. The extrapolated valuesagree with the So values measured in PBS and suggest that
ELP does not form tight complexes in serum that alter its
rate of sedimentation significantly. We cannot exclude
weak complex formation that does not significantly alter
the sedimentation rate. We also note that the slope of the
lines at 20C and 30C vary in the same temperature-depen-
dent manner as the data obtained in PBS (Fig. 5 A), suggest-
ing that the ELP is associating in serum, with itself or serum
components, and masking the nonideality. Note that in this
case, the nonideality is a cross-term effect due to the serum
concentration. As described above, the turbidity data ob-
tained in FBS demonstrate a higher TT than that obtained
in PBS, which implies some favorable interaction with
monomeric ELP that disfavors aggregation. Separate exper-
iments indicated that ELP[V5G3A2-150] and most likely
other ELP constructs exhibit weak attraction to g-globulins.Biophysical Journal 104(9) 2009–2021
2018 Lyons et al.This interaction, and possibly other weak interactions with
less ubiquitous serum proteins, may account for the increase
in the TT in serum. These data will be presented in a separate
publication focusing on the J-O effect in FBS. Alternatively,
changes in hydration or binding of other small serum com-
ponents may contribute to this effect on TT. Future turbidity
and sedimentation experiments with osmolytes will explore
these possibilities.DISCUSSION
ELP is a genetically engineered thermoresponsive
biopolymer that is currently being studied as a means of tar-
geting systemically delivered therapeutics in vivo. We
measured the structural, thermodynamic, and hydrodynamic
properties of ELP[V5G3A2-150], a specific ELP that is being
investigated for drug delivery in cancer model systems,
including cell culture and xenografts in mice. The DLS,
DSC, and turbidity TT data coincide and agree with a coop-
erative aggregation process that involves the release of wa-
ter, as indicated by a large positive DH value. The transition
is coupled to formation of b-turn structures throughout the
temperature range below TT, as indicated by the loss of
random coil and the gain of b-turn structures in the CD
data. This transition is concentration dependent, suggesting
a gradual temperature-dependent association process that is
coupled to conformational changes. This conclusion is sup-
ported by the AUC data, which reveal a nonideal, weak, in-
definite self-association that is nonetheless significant at the
concentrations being investigated both in the biophysical
measurements and in the therapeutic experiments. The
AUC data also reveal a Cc below which no phase change
or aggregation occurs. This equates the TTor the Cc to a sol-
ubility concentration, consistent with the phase change be-
ing a coaservate process in which there is an equilibrium
between phases. The large size of the aggregates as
measured by DLS support this interpretation. Although
much of this is consistent with the literature on ELPs, there
are some new features worth discussing.
The measurement of the RH by DLS allows us to calculate
the compaction index (CI) of ELP[V5G3A2-150], or the de-
gree of compaction relative to globular versus denatured pro-
teins, by comparing the measured RH with the RH calculated
for an unfolded versus a folded protein of the same size. The
CI is presented on a scale of 0 to 1, with 0 indicating a fully
extended conformation and 1 indicating a globular or highly
compact conformation. We use the method presented by
Brocca et al. (47), who defined the CI as
CI ¼ R
D
H  RH
RDH  RFH
0CI ¼ 8:88 nm 6:95 nm
8:88 nm 3:26 nm (7)
The CI for ELP[V5G3A2-150] at 5
C is calculated to be
0.349 using the calculated values from Table 1 and experi-Biophysical Journal 104(9) 2009–2021mentally measured RH from DLS (Table 2) indicating an
extended structure with some minimal compaction. These
results are in agreement with hydrodynamic AUC experi-
ments, which provide the additional advantage of revealing
the presence of self-association. This general discussion
pertains to the observation that IDPs exhibit compaction
values that are intermediate between denatured and folded
states (23). Thus, AUC offers a significant advantage in
measuring f/f0 and RH values because it can reveal the pres-
ence of association, which might also be linked to folding,
compaction, and function. A concerted effort to measure
SV data on a large number of IDPs as a function of temper-
ature and concentration might be useful to demonstrate the
utility of this perspective.
The models for Sedanal fitting of SV data were con-
structed with four assumptions: 1) At 5C, no appreciable
association occurs, and therefore any change in the system
above 5C is caused by temperature-induced association.
This is justified by the fact that these data are best fit by
direct boundary analysis to a nonideal monomeric system
with the correct molecular weight of ELP[V5G3A2-150]
(Fig. S2). This is also supported by the CD and DLS data.
2) No change in the shape (f/f0) of ELP[V5G3A2-150] oc-
curs with increasing temperature. The SV simulations sug-
gest that the decrease in the apparent calculated f/f0 can
be attributed to association, not a change in shape. There-
fore, the sn value of higher-order species was assumed to in-
crease according to a traditional n2/3 model, implying that
the oligomers maintain a similar extended shape like the
monomers (40). This is supported by the RH values seen
in the DLS data at 5C (Fig. 2 and Table 2). 3) The nonideal-
ity or Ks of higher-order species remains constant on a
weight basis. This is a common assumption in the field in
the absence of molecular information about the shapes of di-
mers, trimers, etc. (48,49). For globular proteins this is a
reasonable starting point, based on empirical observations
of the nonideality of BSA and g-globulin dimers remaining
constant relative to monomer (data not shown). To adjust
this, we would need a molecular model as the basis for
bead modeling (40). 4) Finally, the stepwise association
models assumed a constant K for each step but limited the
maximum nmer values to estimate an extent of association.
The isodesmic association model proved to be the best
model and assumed a constant K for each step, Kiso, but
did not limit the maximum size of oligomers included in
the fit. For an isodesmic model, higher oligomers are neces-
sarily less populated on a molar basis due to this constant K
assumption.
The analysis of weakly nonideal associating systems
is intrinsically difficult because Ks and Kiso values numeri-
cally couple in the fitting procedures, and because one must
collect the data at higher concentrations to observe the
association, nonideality will be significant. Thus, if we al-
lowed the 5C nonideality values to float while fitting Kiso
rather than constraining them, significant changes to the
Hydrodynamic Analysis of ELP[V5G3A2-150] 2019association parameters at higher temperatures would occur.
In addition, the sn values, the sedimentation coefficient of
the nth oligomer, are calculated assuming an n2/3 relation-
ship, as well as an assumption about constant shape. As pre-
viously discussed (40), a more realistic assumption about an
extended shape would lower the sn values and thus raise the
Kiso values. For example, if RH varies as N
.285 (Eqs. 1 and
2), the relationship between s1 and sn might drop to n
1/3
and Kiso would increase by 2- to 4-fold (~0.6 kcal/mol),
although the RMSDs of the fits are not as good as those
for the n2/3 model, suggesting that N.509 may be the correct
assumption. (Part of this uncertainty pertains to the actual
mechanism of self-association, how a b-spiral would stabi-
lize intermolecular interactions, and what the shapes of
those oligomers might be. One could envision heteroge-
neous contacts between b-turns that preserve the extended
structure of a proline-rich sequence like ELP. The CD
data suggest other b-structures, but verification by other
methods (e.g., Fourier transform infrared and laser Raman
spectroscopy) is required.) Although the SV experiments
proposed above on a family of IDPs would provide the
data to determine the exact Nv relationship, the additional
feature that association might be linked to folding and
compaction would also apply, and thus each system would
require separate analysis. This reemphasizes the issue dis-
cussed above about fitting parameters coupling and the
need at times to make assumptions about hydrodynamic
and thermodynamic relationships rather than trusting the
best-fitted values for an underdetermined system. Note
that the uncertainty in Kiso is estimated by Fstat analysis
of parameter uncertainty (Table 4), but, as discussed above,
this does not include uncertainty in f/f0 or sn values that
couple with Kiso.
One of the implicit assumptions in this work is that bio-
physical characterization of therapeutic molecules informs
the development process. This is why many of the biotech
companies that are developing therapeutic antibodies
perform AUC analyses on their formulations and in plasma.
Stability and aggregation are the two main issues being
characterized (50,51). Our studies reveal that ELP is stable
and undergoes weak reversible association in PBS. Addi-
tional studies characterizing ELP in FBS and as a function
of serum components (albumin and g-globulin) will be
presented elsewhere. One might ask whether the exact
mechanism or model of ELP[V5G3A2-150]s assembly, ag-
gregation, or solubility matters in terms of therapeutic
development. For example, the idea of an ELP solubility
constant has many similarities to the solubility of Hb-S,
the hemoglobin variant found in sickle cell disease. Hb-S
also exhibits a negative temperature coefficient of solubility,
consistent with processes driven by hydrophobic interac-
tions, and does not undergo a significant structural transition
upon polymerization (52). The stochastic nucleation of
Hb-S involves the formation of a 14-strand nucleus, and
much effort has been spent on developing small-moleculedrugs that might inhibit this nucleation process. The discov-
ery of an ELP Cc suggests that a more complex model
involving nucleation or heterogeneous nucleation may also
be appropriate, similar to Hb-S (52) and microtubule poly-
merization (53). Understanding factors that affect localiza-
tion and aggregation to a site of heating might improve
the efficiency of this process while also minimizing nonspe-
cific localization to other tissues or organs. At the very least,
a quantitative model is required to interpret data collected in
plasma, including bioavailability analysis. Furthermore, the
role of elastin in the physiological environment as an elastic
entropic spring is believed to depend on water release and
hydrophobic collapse into a condensed b-spiral or b-struc-
ture (54). Future analyses are planned to examine the role
of water and the hydrophobic effect in these weak interac-
tions by repeating the sedimentation analyses while
lowering the activity of water and varying the concentra-
tions of additional serum components.
The turbidity data are consistent with previous observa-
tions, including the surprising impact of a small molecule
such as fluorescein causing a 3.5C decrease in TT (3),
and suggests that these measurements need to be made on
the drug complex and not just the delivery system. The anal-
ysis in FBS suggests that the properties of ELP[V5G3A2-
150] are changed in the physiological buffer. The TT was
found to increase by ~2.2C, which also emphasizes the
need to examine the TT in the physiological buffer. To illus-
trate this, based on the TT in PBS, at 42
C 9.8 mM of ELP
[V5G3A2-150] will circulate freely and not aggregate. In
95% FBS, however, 27.39 mM of ELP[V5G3A2-150] will
circulate freely and not aggregate at 42C. SV suggests
that this increase in the TT can be attributed to association
with serum proteins; however, no specific stable complexes
are formed. These conclusions clearly have consequences
for dosage and therapeutic delivery. This is the subject of
separate studies involving CPP and drug-labeled ELP
[V5G3A2-150] constructs.SUPPORTING MATERIAL
Materials, methods, five figures, and one table are available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(13)00379-2.
This work was supported by the University of Mississippi Medical Center
AUC Facility and the National Science Foundation (Major Research Instru-
mentation Grant 1040372 to J.J.C.).REFERENCES
1. Zhang, Y., K. Trabbic-Carlson, ., P. S. Cremer. 2006. Aqueous two-
phase system formation kinetics for elastin-like polypeptides of vary-
ing chain length. Biomacromolecules. 7:2192–2199.
2. Meyer, D. E., and A. Chilkoti. 2004. Quantification of the effects of
chain length and concentration on the thermal behavior of elastin-
like polypeptides. Biomacromolecules. 5:846–851.Biophysical Journal 104(9) 2009–2021
2020 Lyons et al.3. Chilkoti, A., M. R. Dreher, and D. E. Meyer. 2002. Design of thermally
responsive, recombinant polypeptide carriers for targeted drug deliv-
ery. Adv. Drug Deliv. Rev. 54:1093–1111.
4. Urry, D. W., C. H. Luan,., A. Safavy. 1991. Temperature of polypep-
tide inverse temperature transition depends on mean residue hydropho-
bicity. J. Am. Chem. Soc. 113:4346–4348.
5. Urry, D. W. 1992. Free energy transduction in polypeptides and pro-
teins based on inverse temperature transitions. Prog. Biophys. Mol.
Biol. 57:23–57.
6. Bidwell, III, G. L., and D. Raucher. 2010. Cell penetrating elastin-like
polypeptides fortherapeutic peptide delivery. Adv. Drug Deliv. Rev.
3:1486–1496.
7. Bidwell, 3rd, G. L., A. A. Whittom,., D. Raucher. 2010. A thermally
targeted peptide inhibitor of symmetrical dimethylation inhibits can-
cer-cell proliferation. Peptides. 31:834–841.
8. Massodi, I., G. L. Bidwell, 3rd, and D. Raucher. 2005. Evaluation of
cell penetrating peptides fused to elastin-like polypeptide for drug de-
livery. J. Control. Release. 108:396–408.
9. Massodi, I., S. Moktan, ., D. Raucher. 2010. Inhibition of ovarian
cancer cell proliferation by a cell cycle inhibitory peptide fused to a
thermally responsive polypeptide carrier. Int. J. Cancer. 126:533–544.
10. Bidwell, 3rd, G. L., and D. Raucher. 2005. Application of thermally
responsive polypeptides directed against c-Myc transcriptional func-
tion for cancer therapy. Mol. Cancer Ther. 4:1076–1085.
11. Bidwell, 3rd, G. L., and D. Raucher. 2006. Enhancing the antiprolifer-
ative effect of topoisomerase II inhibitors using a polypeptide inhibitor
of c-Myc. Biochem. Pharmacol. 71:248–256.
12. Bidwell, 3rd, G. L., A. N. Davis, and D. Raucher. 2009. Targeting a
c-Myc inhibitory polypeptide to specific intracellular compartments us-
ing cell penetrating peptides. J. Control. Release. 135:2–10.
13. Bidwell, 3rd, G. L., E. Perkins, and D. Raucher. 2012. A thermally tar-
geted c-Myc inhibitory polypeptide inhibits breast tumor growth.
Cancer Lett. 319:136–143.
14. Massodi, I., E. Thomas, and D. Raucher. 2009. Application of ther-
mally responsive elastin-like polypeptide fused to a lactoferrin-derived
peptide for treatment of pancreatic cancer. Molecules. 14:1999–2015.
15. Bidwell, 3rd, G. L., A. N. Davis,., D. Raucher. 2007. A thermally tar-
geted elastin-like polypeptide-doxorubicin conjugate overcomes drug
resistance. Invest. New Drugs. 25:313–326.
16. Bidwell, 3rd, G. L., I. Fokt, ., D. Raucher. 2007. Development of
elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Biochem. Pharmacol. 73:620–631.
17. Moktan, S., C. Ryppa, ., D. Raucher. 2010. A thermally responsive
biopolymer conjugated to an acid-sensitive derivative of paclitaxel sta-
bilizes microtubules, arrests cell cycle, and induces apoptosis. Invest.
New Drugs. 30:236–248.
18. Li, X., P. Romero,., Z. Obradovic. 1999. Predicting protein disorder
for N-, C-, and internal regions. Genome Inform. Ser. Workshop
Genome Inform. 10:30–40.
19. Romero, P., Z. Obradovic, ., A. K. Dunker. 2001. Sequence
complexity of disordered protein. Proteins. 42:38–48.
20. Romero, P., A. Obradovic, and K. Dunker. 1997. Sequence data anal-
ysis for long disordered regions prediction in the calcineurin family.
Genome Inform. Ser. Workshop Genome Inform. 8:110–124.
21. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the
hydropathic character of a protein. J. Mol. Biol. 157:105–132.
22. Wilkins, D. K., S. B. Grimshaw,., L. J. Smith. 1999. Hydrodynamic
radii of native and denatured proteins measured by pulse field gradient
NMR techniques. Biochemistry. 38:16424–16431.
23. Marsh, J. A., and J. D. Forman-Kay. 2010. Sequence determinants of
compaction in intrinsically disordered proteins. Biophys. J. 98:2383–
2390.
24. Farmer, R. S., A. Top,., K. L. Kiick. 2008. Evaluation of conforma-
tion and association behavior of multivalent alanine-rich polypeptides.
Pharm. Res. 25:700–708.Biophysical Journal 104(9) 2009–202125. Yamaoka, T., T. Tamura, ., D. A. Tirrell. 2003. Mechanism for the
phase transition of a genetically engineered elastin model peptide
(VPGIG)40 in aqueous solution. Biomacromolecules. 4:1680–1685.
26. Bandiera, A. P., P. Sist, and R. Urbani. 2010. Comparison of thermal
behavior of two recombinantly expressed human elastin-like polypep-
tides for cell culture applications. Biomacromolecules. 11:3256–3265.
27. Reguera, J., D. W. Urry, ., J. C. Rodrı´guez-Cabello. 2007. Effect of
NaCl on the exothermic and endothermic components of the inverse
temperature transition of a model elastin-like polymer.
Biomacromolecules. 8:354–358.
28. Nicolini, C., R. Ravindra,., R. Winter. 2004. Characterization of the
temperature- and pressure-induced inverse and reentrant transition of
the minimum elastin-like polypeptide GVG(VPGVG) by DSC, PPC,
CD, and FT-IR spectroscopy. Biophys. J. 86:1385–1392.
29. Urry, D. W., R. G. Shaw, and K. U. Prasad. 1985. Polypentapeptide of
elastin: temperature dependence of ellipticity and correlation with elas-
tomeric force. Biochem. Biophys. Res. Commun. 130:50–57.
30. Reiersen, H., A. R. Clarke, and A. R. Rees. 1998. Short elastin-like
peptides exhibit the same temperature-induced structural transitions
as elastin polymers: implications for protein engineering. J. Mol.
Biol. 283:255–264.
31. Gross, P. C., W. Possart, andM. Zeppezauer. 2003. An alternative struc-
ture model for the polypentapeptide in elastin. Z. Naturforsch. C.
58:873–878.
32. Woody, R. W. 1995. Circular dichroism.Methods Enzymol. 246:34–71.
33. Baer, E. A., R. Schreiner,., J. Marx. 2006. Inverse temperature tran-
sition of a biomemetic elastin model: reactive flux of folding/unfolding
and its coupling to solvent dielectric relaxation. Phys. Chem.
110:3576–3587.
34. Stafford, 3rd, W. F. 1992. Boundary analysis in sedimentation transport
experiments: a procedure for obtaining sedimentation coefficient distri-
butions using the time derivative of the concentration profile. Anal.
Biochem. 203:295–301.
35. Philo, J. S. 2006. Improved methods for fitting sedimentation coeffi-
cient distributions derived by time-derivative techniques. Anal.
Biochem. 354:238–246.
36. Pederson, K. O. 1958. On charge and specific ion effects on sedimen-
tation in the ultracentrifuge. J. Phys. Chem. 62:1282.
37. Stafford, 3rd, W. F. 2009. Protein-protein and ligand-protein interac-
tions studied by analytical ultracentrifugation. Methods Mol. Biol.
490:83–113.
38. Na, G. C., and S. N. Timasheff. 1985. Velocity sedimentation study
of ligand-induced protein self-association. Methods Enzymol.
117:459–495.
39. Rowe, A. J. 2011. Ultra-weak reversible protein-protein interactions.
Methods. 54:157–166.
40. Sontag, C. A., W. F. Stafford, and J. J. Correia. 2004. A comparison of
weight average and direct boundary fitting of sedimentation velocity
data for indefinite polymerizing systems. Biophys. Chem. 108:215–230.
41. Dill, K. A., and S. Bromberg. 2003. Molecular Driving Forces, 1st ed.
Garland Science/Taylor & Francis Group, New York.
42. Ellis, R. J. 2001. Macromolecular crowding: obvious but underappreci-
ated. Trends Biochem. Sci. 26:597–604.
43. Johnston, J. P., and A. G. Ogston. 1946. A boundary anomaly found in
the ultracentrifugal sedimentation of mixtures. Trans. Faraday Soc.
42:789–799.
44. Harrington, W. F., and H. K. Schachman. 1952. Analysis of a concen-
tration anomaly in the ultracentrifugation of mixtures. J. Am. Chem.
Soc. 75:3533–3539.
45. Trautman, R., V. N. Schumaker,., H. K. Schachman. 1954. The deter-
mination of concentrations in the ultracentrifugation of two-component
systems. J. Chem. Phys. 22:555–559.
46. Correia, J. J., M. L. Johnson, ., D. A. Yphantis. 1976. Numerical
study of the Johnston-Ogston effect in two-component systems.
Biophys. Chem. 5:255–264.
Hydrodynamic Analysis of ELP[V5G3A2-150] 202147. Brocca, S., L. Testa,., R. Grandori. 2011. Compaction properties of
an intrinsically disordered protein: Sic1 and its kinase-inhibitor
domain. Biophys. J. 100:2243–2252.
48. Frigon, R. P., and S. N. Timasheff. 1975. Magnesium-induced self-as-
sociation of calf brain tubulin. I. Stoichiometry. Biochemistry.
14:4559–4566.
49. Frigon, R. P., and S. N. Timasheff. 1975. Magnesium-induced self-as-
sociation of calf brain tubulin. II. Thermodynamics. Biochemistry.
14:4567–4573.
50. Arakawa, T., J. S. Philo,., F. Arisaka. 2006. Aggregation analysis of
therapeutic proteins, part 1: General aspects and techniques for assess-
ment. Bioprocess Int. 4:42–49.51. Arakawa, T., J. S. Philo,., F. Arisaka. 2006. Aggregation analysis of
therapeutic proteins, part 2: Analytical ultracentrifugation and dynamic
light scattering. Bioprocess Int. 5:36–47.
52. Magdoff-Fairchild, B., W. N. Poillon,., J. F. Bertles. 1976. Thermo-
dynamic studies of polymerization of deoxygenated sickle cell hemo-
globin. Proc. Natl. Acad. Sci. USA. 73:990–994.
53. Vulevic, B., and J. J. Correia. 1997. Thermodynamic and structural
analysis of microtubule assembly: the role of GTP hydrolysis.
Biophys. J. 72:1357–1375.
54. Pollard, T. D., and W. C. Earnshaw. 2008. Cell Biology, 2nd ed.
Elsevier, Philadelphia.Biophysical Journal 104(9) 2009–2021
